Asia’s Only Industry-Dedicated Forum for Degraders & Proximity Drugs
With the first anticipated PROTAC approval and multiple candidates advancing through clinical trials, 2026 is going to be a pivotal year for the global targeted-protein degradation (TPD) industry. This global momentum is fueling Korea’s own TPD boom: over $144M raised in the past 12 months, alongside strategic collaborations from leaders like Ubix Therapeutics, Prazer Therapeutics, and Bridge Biotherapeutics.
The inaugural World TPD & Induced Proximity Summit South Korea is the only event dedicated to gathering the Asian biopharma focused on end-to-end TPD drug development. Featuring key international opinion leaders, deep dives into preclinical and clinical strategy, and expanded content on molecular glues and novel E3 ligases, this summit is your chance to de-risk your pipelines, learn from international experts, and build the global collaborations needed to advance best-in-class TPD therapeutics.
Part of the World Targeted Therapeutics Summit in South Korea organized by Hanson Wade, this is your opportunity to converge with peers working on antibody-drug conjugates (ADCs), Bispecifics, and T-cell engagers, who aim to turn South Korea into the next major global hub for biopharma innovation in targeted therapeutics.
The Biggest Headline of the TPD Industry & a Milestone for the Community: Arvinas Announces the First FDA Approval of a PROTAC
Learn more.
Yuhan Pivots to Targeted Protein Degradation to Tackle ‘Undruggable’ Targets
Learn more.
Ubix Therapeutics Delays Kosdaq IPO, Bets on Valuation Boost From Tech Transfer
Learn more.
Chey Yoon-Chung Takes Hands-on Role to Lead New Venture Push
Learn more.
Download the Official Agenda to Explore:
- Your One-Stop Forum to De-Risk & Develop Best-in-Class TPD Therapeutics
- Insights from 20+ Korean-Based and International Speakers
- Unrivalled Networking Opportunities with Professionals Working on TPD & Induced Proximity, ADCs, Bispecifics & T-Cell Engagers
Speakers
Hanson Wade Summits have been vital in helping me communicate with experts in TPD drug discovery/development, and it has been an absolute pleasure to participate in them.
Changhoon Ji, Executive Director, AUTOTAC Bio
Confirmed Speaker & Previous Attendee of the TPD Summit Series
An excellent opportunity for companies and academia across Asia working on TPD to come together, share insights, and foster collaborations that can lead to meaningful innovation.
Minoru Tanaka, Director, Tanabe Pharma Corporation
Confirmed Speaker
What To Expect
80+
Attendees from Biopharma & Academia
20+
World-Class Speakers
50%
International Leaders Presenting
8
Hours of In-Person Networking
2
Additional Content Areas to Access: ADCs, & Bispecifics & T-Cell Engager
Official Partners
Expertise Partners
Innovation Partner
Exhibition Partners
Attending Companies Include
Explore Related Events
Explore the Agenda
Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.
Partner With Us
Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.